Back to Screener

Financial Services

Boston Partners Long/Short Research Fd Inv Cl(BPRRX)

Live Price

Offline

$13.97

+0.14% today

1Y Change

+2.57%

Window

Jun 25, 2025 โ†’ Jun 24, 2026

Market Cap
$570.00M
Revenue Growth
+42.6%
EPS Growth
-86.8%
Dividend Yield
10.9%

Coverage: 250 bars ยท Jun 25, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Boston Partners Long/Short Research Fd Inv Cl (BPRRX) is a Financial Services stock with a market cap of $570.00M. The stock last traded around $13.97 and up 2.6% across the available one-year price window (Jun 25, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of +42.6%, EPS growth of -86.8%, a dividend yield of 10.9%. What stands out right now is revenue +42.6%, EPS -86.8%, free cash flow -241.6% with operating margin -5.6% and ROIC -0.1%. The dividend matters to the case here, with a current yield around 10.9%. Valuation sits in the middle of the pack at price/sales 7.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines BPRRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.

Benchmark Edge

BPRRX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

BPRRX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

BPRRX Max Drawdown

-12.81%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BPRRX and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

Boston Partners Long/Short Research Fd Inv Cl (BPRRX)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$20.0M

-51.6% YoY

FY Net Income

-$9.1M

-512.9% YoY

Free Cash Flow

-$3.1M

-145.3% YoY

Revenue Growth

+42.6%

EPS Growth

-86.8%

Gross Margin

44.3%

Net Margin

8.8%

Income statement

USD

Annual
Metric20222021202020192018
Revenue81M57M46M41M20M
Gross Profit36M11M20M18M7M
Operating Income-5M-24M-5M-12M-12M
EBITDA11M-13M3M2M-3M
Net Income7M53M-49K-1M-9M
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

USD

Point-in-time
Metric20222021202020192018
Cash & Equivalents25M73M45M16M17M
Total Assets684M807M641M437M332M
Total Liabilities157M166M114M90M12M
Shareholder Equity504M496M382M345M315M
Total Debt27M0000
Net Debt-25M-73M-45M-16M-17M

Cash flow positioning

Latest Full Year

Operating Cash Flow

38K

-99.6% YoY

Capital Expenditures

3M

-11.0% YoY

Free Cash Flow

3M

-145.3% YoY

Key ratios

  • Gross Margin

    44.3%

  • Operating Margin

    -5.6%

  • Net Margin

    8.8%

  • ROE

    1.4%

  • Debt / Equity

    0.05x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.